Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 3M COMMM · Entity 1275 | Exec VP, Gen Counsel & Secret | April 30, 2021 | May 03, 2021 |
| Cboe Global Markets, Inc.CBOE · Entity 3134 | Director | May 14, 2026 | May 18, 2026 |
| Medtronic plcMDT · Entity 2888 | EVP GENERAL COUNSEL & SECR | December 16, 2024 | December 17, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
3M CO
Report date April 30, 2021 · Filed May 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 47,872.4023 |
Reported balance
After 2021-04-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-04-30 · Exercise / conversion · Acquired 12,059 · Balance 47,872.4023 F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2021. |
| Common StockSEC Table I · non-derivative | Direct | 35,813.4023 |
Reported balance
After 2021-04-30 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2021-04-30 · Sale · Disposed 12,059 · Balance 35,813.4023 F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2021. F2: Includes shares acquired pursuant to 3M's Dividend Reinvestment Plan. F3: Includes shares acquired under 3M's General Employee Stock Purchase Plan. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $89.25 · Expires 2022-11-01 | Direct | 23,291 |
Reported balance
After 2021-04-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-04-30 · Exercise / conversion · Disposed 12,059 · Balance 23,291 |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2021.
F2: Includes shares acquired pursuant to 3M's Dividend Reinvestment Plan.
F3: Includes shares acquired under 3M's General Employee Stock Purchase Plan.
Cboe Global Markets, Inc.
Report date May 14, 2026 · Filed May 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,441 |
Reported balance
After 2026-05-14 transaction · row 1
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 530 · Balance 7,441 F1: Represents a restricted stock unit award granted under the Company's Third Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 14, 2027, provided that the filing person has remained in service continuously through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit award granted under the Company's Third Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 14, 2027, provided that the filing person has remained in service continuously through such date.
Medtronic plc
Report date December 16, 2024 · Filed December 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 54,692 |
Reported balance
After 2024-12-16 transaction · row 1
1 source rowRow 1 · 2024-12-16 · Tax withholding · Disposed 532 · Balance 54,692 F1: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2026 Filed May 18, 2026 19:30 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantCommon Stock | 530 | $0.00 | $0.00 |
DisclosureSEC source: 0001342238-26-000001 · form4-05182026_030515.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,441 F1 · price: Represents a restricted stock unit award granted under the Company's Third Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 14, 2027, provided that the filing person has remained in service continuously through such date. Read SEC document |
| May 06, 2025 Filed May 8, 2025 20:39 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantCommon Stock | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012369 · form4-05082025_080532.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,911 F1 · price: Represents a restricted stock unit award granted under the Company's Third Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 6, 2026, provided that the filing person has remained in service continuously through such date. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 16:59 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 532 | $82.48 | $43,879.36 |
DisclosureSEC source: 0001613103-24-000176 · wk-form4_1734472741.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,692 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility. Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 17:01 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 3,009 | $83.58 | $251,492.22 |
DisclosureSEC source: 0001613103-24-000171 · wk-form4_1733954499.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,224 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. F2 · balance_after: Includes 270 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 18:11 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Units · Derivative | 6,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000111 · wk-form4_1722982277.xml · derivative · entry 7 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 6,144 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 2, 2024. F5 · derivative.expiration_date: The performance share units vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 18:11 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Units · Derivative | 8,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000111 · wk-form4_1722982277.xml · derivative · entry 6 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 8,370 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 2, 2024. F5 · derivative.expiration_date: The performance share units vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 18:11 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 2,985 | $81.51 | $243,307.35 |
DisclosureSEC source: 0001613103-24-000111 · wk-form4_1722982277.xml · nonDerivative · entry 5 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,963 F3 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 18:11 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 2,802 | $81.51 | $228,391.02 |
DisclosureSEC source: 0001613103-24-000111 · wk-form4_1722982277.xml · nonDerivative · entry 4 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,948 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units units that vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 18:11 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 6,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000111 · wk-form4_1722982277.xml · nonDerivative · entry 3 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on February 1, 2022 and earned dividend equivalents. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 18:11 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 3,423 | $81.51 | $279,008.73 |
DisclosureSEC source: 0001613103-24-000111 · wk-form4_1722982277.xml · nonDerivative · entry 2 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,606 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units units that vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 18:11 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 8,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000111 · wk-form4_1722982277.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on February 1, 2022 and earned dividend equivalents. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 19:59 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 94,248 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000086 · wk-form4_1722470338.xml · derivative · entry 3 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,248 Underlying: Ordinary Shares · 94,248 shares Expires 2034-07-29 F6 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 19:59 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Unit · Derivative | 31,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000086 · wk-form4_1722470338.xml · derivative · entry 2 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,875 Underlying: Performance Share Units · 31,875 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Vests July 29, 2027. F4 · derivative.expiration_date: Vests July 29, 2027. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 31,875 shares will be issued. If maximum performance metrics are achieved, 63,750 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 19:59 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 12,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000086 · wk-form4_1722470338.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,659 F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 708 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 16, 2024 Filed May 20, 2024 20:36 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantCommon Stock | 937 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-013765 · form4-05202024_080509.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,182 F1 · price: Represents a restricted stock unit award granted under the Company's Second Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 16, 2025, provided that the filing person has remained in service continuously through such date. Read SEC document |
| December 11, 2023 Filed Dec 12, 2023 14:53 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 1,952 | $79.35 | $154,891.20 |
DisclosureSEC source: 0001613103-23-000161 · wk-form4_1702410790.xml · nonDerivative · entry 2 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,201 F2 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. F3 · balance_after: Includes 1,062 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 14:53 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 716 | $79.27 | $56,757.32 |
DisclosureSEC source: 0001613103-23-000161 · wk-form4_1702410790.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,091 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 19:46 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 56,162 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001613103-23-000072 · wk-form4_1691019985.xml · derivative · entry 3 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,162 Underlying: Ordinary Shares · 56,162 shares Expires 2033-07-31 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 19:46 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 19,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000072 · wk-form4_1691019985.xml · derivative · entry 2 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,941 Underlying: Performance Share Units · 19,941 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 19,941 shares will be issued. If maximum performance metrics are achieved, 39,882 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F5 · derivative.exercise_date: Vests on July 31, 2026. F5 · derivative.expiration_date: Vests on July 31, 2026. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 19:46 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 7,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000072 · wk-form4_1691019985.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,807 F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 641 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:41 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantCommon Stock | 1,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008000 · form4-05152023_080508.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,245 F1 · price: Represents a restricted stock unit award granted under the Company's Second Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 11, 2024, provided that the filing person has remained in service continuously through such date. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:57 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 5,206 | $78.59 | $409,139.54 |
DisclosureSEC source: 0001127602-22-027403 · form4.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,830 F1 · balance_after: This balance increased by 314 shares due to exempt acquisitions through dividend reinvestment. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 17:32 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 54,849 | $0.00 Strike: $93.08 | $0.00 |
DisclosureSEC source: 0001127602-22-020410 · form4.xml · derivative · entry 3 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,849 Underlying: Ordinary Shares · 54,849 shares Expires 2032-08-01 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 17:32 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 17,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020410 · form4.xml · derivative · entry 2 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,351 Underlying: Performance Share Units · 17,351 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 17,351 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F5 · derivative.exercise_date: Vests on August 1, 2025. F5 · derivative.expiration_date: Vests on August 1, 2025. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 17:32 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 6,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020410 · form4.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,722 F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: This balance increased by 410 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:22 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | PurchaseCommon Stock | 650 | $109.27 | $71,025.50 |
DisclosureSEC source: 0001415889-22-005314 · form4-05192022_010506.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,022 Read SEC document |
| May 12, 2022 Filed May 16, 2022 20:14 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantCommon Stock | 1,448 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005011 · form4-05162022_010555.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,372 F1 · price: Represents a restricted stock award granted under the Company's Second Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 18:25 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 21,238 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-003243 · form4.xml · derivative · entry 6 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,238 Underlying: Performance Share Units · 21,238 shares Expires not disclosed F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F8 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,238 shares will be issued. The actual number of shares to be issued could range from a low of 4,248 at minimum performance to a high of 42,476 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F6 · derivative.exercise_date: Vests on August 2, 2024. F6 · derivative.expiration_date: Vests on August 2, 2024. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 18:25 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 145,852 | $103.59 Strike: $103.59 | $15,108,808.68 |
DisclosureSEC source: 0001127602-22-003243 · form4.xml · derivative · entry 5 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,852 Underlying: Ordinary Shares · 145,852 shares Expires 2032-02-01 F7 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 18:25 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 15,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-003243 · form4.xml · derivative · entry 4 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,591 Underlying: Performance Share Units · 15,591 shares Expires not disclosed F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,591 shares will be issued. The actual number of shares to be issued could range from a low of 3,118 at minimum performance to a high of 31,182 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F6 · derivative.exercise_date: Vests on August 2, 2024. F6 · derivative.expiration_date: Vests on August 2, 2024. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 18:25 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 50,476 | $103.59 Strike: $103.59 | $5,228,808.84 |
DisclosureSEC source: 0001127602-22-003243 · form4.xml · derivative · entry 3 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,476 Underlying: Ordinary Shares · 50,476 shares Expires 2031-08-02 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the date noted. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 18:25 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 24,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-003243 · form4.xml · nonDerivative · entry 2 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,371 F2 · kind: The restrictions on these restricted stock units shall vest 50% on December 10, 2022, 25% on December 10, 2023 and 25% on December 10, 2024. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 18:25 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 6,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-003243 · form4.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,237 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on August 2, 2024. Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:13 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantCommon Stock | 1,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005397 · edgar.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,924 F1 · price: Represents a restricted stock award granted under the Company's Second Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Read SEC document |
| April 30, 2021 Filed May 3, 2021 19:30 UTC | 3M CO MMM · Entity 1275 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 12,059 | $0.00 Strike: $89.25 | $0.00 |
DisclosureSEC source: 0001127602-21-014899 · form4.xml · derivative · entry 3 Fong Ivan K · CIK 0001342238 · Exec VP, Gen Counsel & Secret 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,291 Underlying: Common Stock · 12,059 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2021 Filed May 3, 2021 19:30 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 12,059 | $198.46 | $2,393,229.14 |
DisclosureSEC source: 0001127602-21-014899 · form4.xml · nonDerivative · entry 2 Fong Ivan K · CIK 0001342238 · Exec VP, Gen Counsel & Secret 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,813.4023 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2021. F2 · balance_after: Includes shares acquired pursuant to 3M's Dividend Reinvestment Plan. F3 · balance_after: Includes shares acquired under 3M's General Employee Stock Purchase Plan. Read SEC document |
| April 30, 2021 Filed May 3, 2021 19:30 UTC | 3M CO MMM · Entity 1275 | Exercise / conversionCommon Stock | 12,059 | $89.25 | $1,076,265.75 |
DisclosureSEC source: 0001127602-21-014899 · form4.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · Exec VP, Gen Counsel & Secret 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,872.4023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2021. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 00:25 UTC | 3M CO MMM · Entity 1275 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 29,023 | $0.00 Strike: $175.02 | $0.00 |
DisclosureSEC source: 0001127602-21-003850 · form4.xml · derivative · entry 3 Fong Ivan K · CIK 0001342238 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,023 Underlying: Common Stock · 29,023 shares Expires 2031-02-01 F5 · derivative.exercise_date: The stock option will vest and become exercisable in a series of three equal installments on each of the first, second and third anniversary of the grant date. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 00:25 UTC | 3M CO MMM · Entity 1275 | Tax withholdingCommon Stock | 66.966 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-003850 · form4.xml · nonDerivative · entry 2 Fong Ivan K · CIK 0001342238 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,608.6123 F4 · shares: The number of shares withheld for taxes was estimated and will be revised by amendment if necessary. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 00:25 UTC | 3M CO MMM · Entity 1275 | GrantCommon Stock | 2,687.161 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-003850 · form4.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,675.5783 F1 · shares: Represents shares of 3M common stock that will be delivered pursuant to the terms of a performance share award made to the reporting person on March 1, 2018. The performance-based vesting requirements applicable to such award were satisfied on the date reported in Column 2 above, which represents the date on which the level of performance attained was certified. The reporting person previously elected to defer receipt of the shares and will not have voting or investment powers with respect to such shares until they are issued. F2 · balance_after: Includes shares acquired under 3M's General Employee Stock Purchase Plan. F3 · balance_after: Includes dividend share equivalents, accrued quarterly, pursuant to 3M's Deferred Compensation Plan. Read SEC document |
| February 01, 2021 Filed Feb 16, 2021 18:24 UTC Amendment | 3M CO MMM · Entity 1275 | Tax withholdingCommon Stock | 113.561 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005746 · form4a.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,562.0173 F1 · shares: The number of shares previously reported as being withheld for the payment of taxes was estimated. This amendment is being filed to update the Form 4 with the actual number of shares withheld. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 21:45 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantCommon Stock | 648 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-012128 · edgar.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 648 F1 · price: Represents a restricted stock award granted under the Company's Second Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 19:01 UTC | 3M CO MMM · Entity 1275 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 15,073 | $0.00 Strike: $89.25 | $0.00 |
DisclosureSEC source: 0001127602-20-029201 · form4.xml · derivative · entry 3 Fong Ivan K · CIK 0001342238 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,350 Underlying: Common Stock · 15,073 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 19:01 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 15,073 | $172.62 | $2,601,901.26 |
DisclosureSEC source: 0001127602-20-029201 · form4.xml · nonDerivative · entry 2 Fong Ivan K · CIK 0001342238 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,812.5527 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2020. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 19:01 UTC | 3M CO MMM · Entity 1275 | Exercise / conversionCommon Stock | 15,073 | $89.25 | $1,345,265.25 |
DisclosureSEC source: 0001127602-20-029201 · form4.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,885.5527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2020. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 22:14 UTC | 3M CO MMM · Entity 1275 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 34,395 | $0.00 Strike: $157.24 | $0.00 |
DisclosureSEC source: 0001127602-20-004030 · form4.xml · derivative · entry 3 Fong Ivan K · CIK 0001342238 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,395 Underlying: Common Stock · 34,395 shares Expires 2030-02-03 F4 · derivative.exercise_date: The stock option will vest and become exercisable in a series of three equal installments on each of the first, second and third anniversary of the grant date. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 22:14 UTC | 3M CO MMM · Entity 1275 | Tax withholdingCommon Stock | 1,530.114 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004030 · form4.xml · nonDerivative · entry 2 Fong Ivan K · CIK 0001342238 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,921.7342 F3 · shares: The number of shares withheld for taxes was estimated and will be revised by amendment, if necessary. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 22:14 UTC | 3M CO MMM · Entity 1275 | GrantCommon Stock | 4,927.52 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004030 · form4.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,451.8482 F1 · shares: Represents shares of 3M common stock that will be delivered pursuant to the terms of a performance share award made to the reporting person on March 1, 2017. The performance-based vesting requirements applicable to such award were satisfied on the date reported in Column 2 above, which represents the date on which the level of performance attained was certified. The reporting person previously elected to defer receipt of the shares and will not have voting or investment powers with respect to such shares until they are issued. F2 · balance_after: Includes shares acquired under 3M's General Employee Stock Purchase Plan. Read SEC document |
| February 04, 2020 Filed Feb 21, 2020 19:09 UTC Amendment | 3M CO MMM · Entity 1275 | Tax withholdingCommon Stock | 185.928 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006863 · form4a.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · SVP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,265.9202 F1 · shares: The number of shares previously reported as being withheld for the payment of taxes was estimated. This amendment is being filed to update the Form 4 with the actual number of shares withheld. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 17:00 UTC | 3M CO MMM · Entity 1275 | GrantIncentive Stock Option (Right to Buy) · Derivative | 19,904 | $0.00 Strike: $201.12 | $0.00 |
DisclosureSEC source: 0001127602-19-004404 · form4.xml · derivative · entry 3 Fong Ivan K · CIK 0001342238 · Sr. VP, Legal & Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,904 Underlying: Common Stock · 19,904 shares Expires 2029-02-04 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.